CSL Praises Austria’s ‘Pioneering Funding Solution’ For Gene Therapy Hemgenix
Executive Summary
The new commercial agreement in Austria is “a strong signal” of how innovative and collaborative thinking can bring a transformative impact for patients, says CSL Behring.